Inactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (hemofil®m)-Reference-Cited by-同舟云学术

Inactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (hemofil®m)

Published:1989-09 Issue:5 Volume:55 Page:627-634
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Piszkiewicz Dennis,Sun Chong-Son,Tondreau Sue C.

Publisher

Elsevier BV

Subject

Hematology

Reference12 articles.

1. Survey of non-U.S. hemophilia treatment centers for HIV seroconversions following therapy with heat-treated factor concentrates;Centers for Disease Control;M.M.W.R.,1987

2. Safety of therapeutic products used for hemophilia patients;Centers for Disease Control;M.M.W.R.,1988

3. Virucidal treatment of clotting factor concentrates;Mannucci;Lancet,1988

4. Acute hepatitis B infection after treatment with heat-inactivated factor VIII concentrate;Brackmann;Lancet,1988

5. Safety of pasteurised factor VIII (Haemate HS);Delvos;Lancet,1988

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and introduction of recombinant factor VIII - a clinician’s experience;Haemophilia;2012-04-19

2. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system;Vox Sanguinis;2006-07

3. Fractionation, Plasma;Kirk-Othmer Encyclopedia of Chemical Technology;2004-07-16

4. An adventure in biotechnology: the development of haemophilia A therapeutics ‒ from whole-blood transfusion to recombinant DNA to gene therapy;Biotechnology and Applied Biochemistry;2002-04-01

5. Viral Inactivation;Blood Safety and Surveillance;2001-01-09